Adrenergic agonists and antagonists as antiglaucoma agents: a literature and patent review (2013-2019)
{{output}}
Introduction: Glaucoma is a neurodegenerative disease of the eye characterized by selective retinal ganglion cell loss that provokes progressive defects in the visual field. Elevated intraocular pressure (IOP) is an important contributor for the progression of... ...
